Suggestions
Nancy White
Strategic Commercial Leader, CEO & Member of the Board
Nancy White is the Chief Executive Officer and a member of the Board at Inagene Diagnostics Inc., a Canadian pharmacogenetic testing company based in Toronto. She has held the CEO position since May 2019, after serving as Vice President of Sales and Marketing at the same company for several months prior to her appointment.12
Professional Background
Nancy White brings over 20 years of experience in the healthcare sector, particularly in sales, marketing, operations, and strategy. Her career includes significant roles at major pharmaceutical companies such as Novartis, Allergan, and Eli Lilly. At Novartis, she held various senior executive positions, including Vice President for Oncology Solid Tumors and Global Team Lead for Advancing Commercial Excellence.23 Her expertise spans across multiple therapeutic areas, including oncology and specialty care, where she has successfully managed the launch and lifecycle of over 25 healthcare brands.2
Education
Nancy holds a Bachelor of Commerce degree from Saint Mary's University and has participated in various executive leadership programs, including those focused on commercial excellence and female leadership at Novartis.3
Contributions to Pharmacogenomics
Under her leadership, Inagene Diagnostics focuses on pharmacogenomic testing to optimize medication prescriptions based on individual genetic profiles. This approach aims to reduce adverse drug reactions and improve treatment efficacy, particularly for patients with chronic pain and mental health conditions.45 Nancy has been an advocate for integrating pharmacogenomic testing into routine healthcare practices in Canada, emphasizing its potential to enhance patient outcomes and reduce healthcare costs.4
Current Role
As CEO, Nancy White continues to drive Inagene's mission to provide comprehensive genetic insights that guide drug selection and treatment, positioning the company as a leader in personalized medicine within Canada.14
